Healthcare -
Biotechnology - NASDAQ - US
$ 6.7
-8.34 %
$ 70.1 M
Market Cap
0.07
P/E
AVTX - NET INCOME
Net Income AVTX - Avalo Therapeutics, Inc.
-31.5 M
LAST VALUE
38.86%
2 YEAR CAGR
4.66%
5 YEAR CAGR
-9.23%
10 YEAR CAGR